|
Market Closed -
Deutsche Boerse AG
02:04:54 2026-09-18 am EDT
|
5-day change | 1st Jan Change | ||
| 0.7110 EUR | 0.00% |
|
+0.71% | -47.87% |
| Sep. 10 | Certain Ordinary Shares of AB Science S.A. are subject to a Lock-Up Agreement Ending on 11-SEP-2026. | CI |
| Aug. 17 | AB Science completes settlement and delivery of its private placement |  |
| Market Cap | 56.41M 64.69M 53.26M 48.37M 90.62M 6.21B 91M 638M 246M 3.16B 243M 238M 10.15B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 56.41M 64.69M 53.26M 48.37M 90.62M 6.21B 91M 638M 246M 3.16B 243M 238M 10.15B | EV / Sales 2026 * |
47x | EV / Sales 2027 * | 43.4x |
| Free-Float |
69.03% | Yield 2026 * |
-
| Yield 2027 * | - |
Deutsche Boerse AGEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| AB | Real-time | |
London S.E.
| 0Q77 | Delayed | |
|
CBOE
| ABp | Real-time | |
|
Tradegate
| A8D | Real-time | |
|
Börse Stuttgart
| A8D | Delayed | |
|
Deutsche Boerse AG
| A8D | Delayed | |
|
CBOE
| 0Q77 | Real-time | |
|
Boerse Muenchen
| A8D | Real-time |
Last Transcript: AB Science
| 1 week | +0.71% | ||
| Current month | -0.84% | ||
| 1 month | +1.43% | ||
| 3 months | -16.35% | ||
| 6 months | -41.43% | ||
| Current year | -47.87% |
| 1 week | 0.71 |  | 0.72 |
| 1 month | 0.67 | | 0.74 |
| Current year | 0.52 | | 1.55 |
| 1 year | 0.52 | | 1.55 |
| 3 years | 0.52 | | 3.71 |
| 5 years | 0.52 | | 13.81 |
| 10 years | 0.52 | | 20.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2026-07-06 | |
Laurent Guy
DFI | Director of Finance/CFO | - | 2009-11-19 |
| Chief Tech/Sci/R&D Officer | - | 2018-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alain Moussy
CHM | Chairman | - | 2001-07-10 |
Patrick Moussy
BRD | Director/Board Member | - | 2011-09-19 |
| Director/Board Member | 65 | 2021-06-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +0.71% | - | - | 64.69M | |
| -0.19% | +2.04% | +80.19% | +36.87% | 362B | |
| -1.22% | -1.22% | +19.95% | -19.05% | 64.74B | |
| +2.53% | +4.90% | +44.52% | +183.96% | 12.76B | |
| -0.29% | +2.94% | -4.00% | -15.43% | 7.53B | |
| -1.89% | -2.14% | -31.54% | -12.10% | 4.38B | |
| -2.06% | -4.41% | -36.00% | +6.54% | 4.08B | |
| +1.48% | +3.64% | -29.60% | -13.12% | 2.96B | |
| -2.14% | +0.86% | -8.77% | +51.84% | 2.44B | |
| -0.41% | +1.15% | -23.58% | -34.10% | 1.93B | |
| Average | -0.42% | +0.50% | +1.24% | +20.60% | 51.46B | |
| Weighted average by Cap. | -0.29% | +1.57% | +65.73% | +30.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.2M 1.38M 1.13M 1.03M 1.93M 132M 1.94M 13.57M 5.24M 67.14M 5.17M 5.05M 216M | 1.3M 1.49M 1.23M 1.11M 2.09M 143M 2.1M 14.7M 5.67M 72.73M 5.6M 5.48M 234M |
| Net income | - | - |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
Sep. 30
Earnings release - Q2 2026
| Date | Price | Change |
|---|---|---|
| 26-09-18 | €0.7110 | 0.00% |
| 26-09-17 | €0.7110 | +0.71% |
| 26-09-16 | €0.7060 | -1.53% |
| 26-09-15 | €0.7170 | -1.24% |
| 26-09-14 | €0.7260 | +2.83% |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AB Stock
- A8D Stock
Select your edition
All financial news and data tailored to specific country editions
